ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 11 of 4530 for:    Recruiting, Not yet recruiting, Available Studies | "Psychotic Disorders"

Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02155699
Recruitment Status : Recruiting
First Posted : June 4, 2014
Last Update Posted : May 2, 2018
Sponsor:
Collaborators:
University of Colorado, Denver
National Institute of Mental Health (NIMH)
Northwestern University
Information provided by (Responsible Party):
Vijay Mittal, University of Colorado, Boulder

Brief Summary:
The goal of this proposal is to test the feasibility and effectiveness of cardiovascular exercise in promoting brain health and improving related symptoms (e.g., hearing sounds that are not there, feeling emotionally detached from self and others), cognitive difficulties (troubles with memory and learning), and every day social-occupational functioning in youth at imminent risk for developing a psychotic disorder such as schizophrenia. Understanding how exercise may protect or improve the health of a brain area that is implicated as a major contributing factor to the onset of psychosis may lead to a path-breaking new intervention that does not suffer from many of the side effects, costs, and other barriers that characterize treatments that are currently available for this group. Because a significant portion of high-risk youth go on to develop a psychotic disorder in a short period, intervening at this stage may help to improve the clinical course and ultimately prevent the onset of a devastating and prevalent mental illness.

Condition or disease Intervention/treatment Phase
Attenuated Psychosis Syndrome Behavioral: Exercise 1 Behavioral: Exercise 2 Not Applicable

Detailed Description:
Accumulating evidence from the animal literature, healthy populations, and schizophrenia studies suggests that regular exercise positively affects integral functions such as neurogenesis, synaptic plasticity and cognition. Likewise, preliminary evidence suggests that aerobic activity has been associated with improved quality of life and a lower level of symptoms in patients with schizophrenia. Because exercise has been found to stimulate human medial temporal neurogenesis, and related abnormalities have been widely observed in studies of schizophrenia, physical activity may be in an important intervention. During the psychosis prodrome, a period immediately proceeding formal onset of psychotic disorders, adolescents experience subtle attenuated symptoms coupled with cognitive deterioration and a global decline in socio-occupational functioning and anywhere between 10-35% go on to transition to a psychotic disorder such as schizophrenia in a two-year period. Despite the promise of exercise interventions, and the critical role medial temporal lobe abnormalities play in etiological models of psychosis, there have been no experimental studies of aerobic exercise in ultra-high risk youth (UHR). Understanding the potential benefits of aerobic exercise in UHR youth is integral as the prodrome is a viable period of intervention in which considerable brain development is still occurring. Further, as there have been challenges associated with many of the available interventions, and an increasing level of potential found in neuroplasticity-based interventions, understanding the effect of exercise on respective brain-behavior holds considerable promise. Experimental research is sorely needed to determine if prescribed aerobic exercise can stimulate medial-temporal neurogenesis and ameliorate cognition and symptoms/functioning in this vital group. In the proposed study, an expert team of experienced prodromal and exercise investigators will follow a group of 15 UHR adolescent and young adults (ages 16-24) through a 12 week exercise trial to determine which level of exercise intensity/frequency is tolerable for participants and optimal for improving aerobic fitness (65% of VO2max and 2 sessions per week versus 85% intensity and 3 sessions per peek) and if improvements in aerobic fitness (i.e., VO2max, VO2peak, ventilatory threshold) are associated with increases in medial temporal structure volume (hippocampus and parahippocampal gyrus) and accompanying improvements in cognitive function (i.e., including tasks known to recruit heavily on medial temporal structures) as well as symptomatology and social/role functioning. If the benchmarks are met, this data will be used to streamline a three-year rater-blind controlled trial (15 UHR-exercise, 15 UHR waitlist-control) to determine the efficacy of the intervention in promoting medial temporal health as well as accompanying cognitive, clinical, and socio-occupational function improvement. Participants will be followed up to 24-months to determine if the intervention has an affect on clinical course and transition to psychosis. Taken together, this study is important for understanding the lessons necessary for planning a future large-scale trial, and has the potential to shed light on a promising new treatment for UHR youth.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 45 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Exercise and Markers of Medial Temporal Health in Youth at Ultra High-risk for Psychosis
Study Start Date : July 2014
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : June 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Exercise 1
65% of V02 Max, 3x per week, 3 months
Behavioral: Exercise 1
65% of VO2max and 2 sessions per week

Experimental: Exercise 2
85% of VO2 Max, 2x per week, 3 months
Behavioral: Exercise 2
85% intensity and 3 sessions per peek

No Intervention: Waitlist
Waitlist (three months)



Primary Outcome Measures :
  1. Brain Volume [ Time Frame: pre-trial, post-trial (3-months) ]
    Medial temporal structures (hippocampus and parahippocampal gyrus) will be delineated automatically using the FMRIB's Integrated Registration and Segmentation Tool algorithm within the FMRIB's Software Library (FSL) image-processing suite (Patenaude, 2007). Secondly, the structures will be evaluated with vertex analyses (assessing changes in shape post trial on a per-vertex basis), which will also be carried out utilizing FIRST. Shape/appearance models used in FIRST are constructed from manually segmented images provided by the Center for Morphometric Analysis (CMA, Boston). This approach is different from using a whole-structure summary measure like volume, as it allows visualization of the region of the shape that is changing as well as the type of shape change.


Secondary Outcome Measures :
  1. Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery, Relational and Item Specific Encoding and Retrieval (RISE) task. [ Time Frame: pre-trial, post-trial (3-months) ]
    The MATRICS battery (Green & Nuechterlein, 2004) includes: the Brief Assessment of Cognition in Schizophrenia (BACS), Symbol-Coding, Animal Naming, Trail Making Test A, Continuous Performance Test—Identical Pairs, Spatial Span, Letter-Number Span, Hopkins Verbal Learning Test—Revised™ (HVLT-R™), Brief Visuospatial Memory Test—Revised (BVMT-R), Neuropsychological Assessment Battery (NAB): Mazes, and the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT): Managing Emotions. Standard T-scores will be evaluated for each test. The RISE (Ragland et al., 2012) task includes visual object representations of word stimuli. Subjects make a two-button "yes/no" response to indicate whether items in each pair had been presented "together." To prevent additional encoding of the relational object pairs the item recognition task precedes the associated recognition task. Scores reflect the familiarity and recollection performance as well as hit rates and false alarm rates following encoding.


Other Outcome Measures:
  1. Attenuated Symptoms and Social/Role Function [ Time Frame: pre-trial, post-trial (3-months), 12 months, 24 months ]
    The Structured Interview for Prodromal Symptoms (SIPS) (Miller et al., 1999) will be administered to formally assess attenuated positive, negative and disorganized symptoms after inclusion in the study. It will also be administered post-trial to track changes in clinical symptoms post intervention trial. The SIPS rates the severity of relevant dimensions including positive, negative and disorganized symptoms along a 7-point scale ranging from absent to severe and psychotic. Role and social functioning will be assessed with the Global Functioning Scale: Role (GFS-R) (Niendam et al., 2006), and the Global Functioning Scale: Social (GFS-S) (Auther et al., 2006), which provide ratings on two separate 10-point Likert scales. The SIPS and GFS-R/S will be administered at annual clinical assessments following completion of the study to track changes in clinical course and determine any cases of transition to psychosis.

  2. Aerobic Fitness [ Time Frame: pre-trial, post-trial (3 months), 12 months, 24 months ]
    V02 Max



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years to 24 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • age 16-24
  • no history of brain injury or neurological disease
  • no contraindications to exercise training (as assessed by a Clinical Translational Research Center CTRC physician)
  • no history or current treatment with antipsychotics
  • no contraindications for being in an magnetic resonance imaging scanner.
  • meet criteria for a prodromal syndrome based upon the Structure Interview for Prodromal Syndromes (SIPS) interview.

Exclusion Criteria:

  • people who are extremely claustrophobic
  • have a history of significant head injury
  • other physical disorder that could affect brain functioning
  • mental retardation
  • history of substance use disorder within 6 months of screening interview
  • have a psychotic disorder (at study entry) and/or have exhibited serious self-harm behaviors
  • pregnant females
  • people who have contraindications to magnetic resonance (MR) scanning including intracranial, intraorbital or intraspinal metal, pacemakers, cochlear implants or other non-MR-compatible devices
  • inability of the subject or their parent/guardian to understand the informed consent document
  • meeting criteria for an Axis I psychotic disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02155699


Contacts
Contact: Vijay A Mittal, Ph.D. (303) 492-3303 vijay.mittal@colorado.edu

Locations
United States, Colorado
ADAPT Program Recruiting
Boulder, Colorado, United States, 80309
Contact: Tina Gupta, B.A.    303-492-4616    adaptprogram@colorado.edu   
Sponsors and Collaborators
University of Colorado, Boulder
University of Colorado, Denver
National Institute of Mental Health (NIMH)
Northwestern University
Investigators
Principal Investigator: Vijay A Mittal, Ph.D. University of Colorado, Boulder
Principal Investigator: Angela Bryan, Ph.D. University of Colorado, Boulder

Additional Information:
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Vijay Mittal, Assistant Professor, University of Colorado, Boulder
ClinicalTrials.gov Identifier: NCT02155699     History of Changes
Other Study ID Numbers: CU 14-0200
4R33MH103231-03 ( U.S. NIH Grant/Contract )
First Posted: June 4, 2014    Key Record Dates
Last Update Posted: May 2, 2018
Last Verified: April 2018

Keywords provided by Vijay Mittal, University of Colorado, Boulder:
UHR, Remediation, Exercise, Intervention, Psychosis

Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders
Schizophrenia Spectrum and Other Psychotic Disorders